Learn More
MedChemExpress LSKL, Inhibitor of Thrombospondin (TSP-1)
Description
LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier.
Specifications
Specifikationer
| CAS | 283609-79-0 |
| Content And Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| For Use With (Application) | Cancer-Kinase/protease |
| Molecular Weight (g/mol) | 458.6 g/mol |
| Product Type | Peptides |
| Quantity | 10 mg |
| Shipping Condition | Room temperature |
| Solubility | DMSO : ≥ 100 mg/mL (218.05 mM) ∣H2O : 50 mg/mL (109.03 mM∣Need ultrasonic) |
Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.